TRPM8 and prostate carcinoma: Inhibition of the ubiquitination cascade increases the activity of the TRPM8 channel in the plasma membrane which has been proposed as a therapeutic strategy for regulating cell growth and proliferation in prostate cancer cells (Asuthkar et al., 2015b; Asuthkar et al., 2017).